Last Updated:
Access Report
Name Designation Appointment Date Status
Ishtiyaque Ilyas Shaikh

Appointed as Director since September 2016

 Director 05-Sep-2016 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Abdulla Patel Mohamed Yusuf

Appointed as Director since January 1994

 Director 24-Jan-1994 Current

People Timeline

Explore the timeline of key personnel in Therapeutics Investments Private Limited's leadership journey.

Contact Details
  • Address Al-Hashmi, 24 Motlibai Street,Agripada, Mumbai-400 011., Mumbai 400 011 Maharashtra, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Therapeutics Investments Private Limited?
You can contact Therapeutics Investments Private Limited through their registered address at Al-Hashmi, 24 Motlibai Street,Agripada, Mumbai-400 011., Mumbai 400 011 Maharashtra, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Therapeutics Investments Private Limited?
The current directors of Therapeutics Investments Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ISHTIYAQUE ILYAS SHAIKH
  • ABDULLA PATEL MOHAMED YUSUF
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available